NEW YORK (GenomeWeb) – Agilent Technologies said after the close of the market on Tuesday that revenues for its fiscal first quarter rose 2 percent year over year, as the company matched the average analysts' estimates on the top and bottom lines. 

For the three months ended Jan. 31, Agilent record $1.03 billion in revenues, equaling the consensus Wall Street estimate. Agilent CFO Didier Hirsch said on a conference call following the release of the firm's financial results that currency effects negatively impacted Q1 2015 revenues by $12 million and EPS by $.01.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.